Scientific publications or press releases from Insitro or Eli Lilly

Insitro and Eli Lilly Announce AI Deal to Accelerate Genetic Medicine Development

Oct 9, 2024, 03:30 PM

Insitro has announced a collaboration with Eli Lilly and Company to accelerate the development of Insitro's genetic medicine using Lilly's proprietary GalNAc delivery technology and expertise in biologics design. The partnership aims to bring Insitro's discoveries to the clinic, with the first drug expected to enter clinical trials by 2026. Insitro retains full global rights to its discoveries, while Lilly is eligible to receive potential benefits from the collaboration. The collaboration also includes an AI deal between Insitro and Eli Lilly.